| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total research and development | 2,184,318 | 2,001,948 | 7,772,109 | NaN |
| Total general and administrative | 5,738,904 | 3,584,316 | 6,579,735 | NaN |
| Operating loss | -7,923,222 | -5,586,264 | -5,995,835 | NaN |
| Issuance cost and change in fair value of derivative | NaN | 133,991 | 1,016,682 | NaN |
| Change in fair value of derivative | 852,030 | NaN | NaN | NaN |
| Interest and other income (expense), net | NaN | NaN | -573,058 | NaN |
| Interest and income (expense), net | -536,837 | -1,361,130 | NaN | NaN |
| Loss before income taxes | -9,312,089 | -6,272,910 | -7,585,575 | NaN |
| Net loss and comprehensive loss | -9,312,089 | -6,272,910 | -7,585,575 | -8,591,426 |
| Depreciation | 121,185 | 121,832 | 106,782 | 312,280 |
| Stock-based compensation | 593,100 | 385,965 | 592,824 | 545,039 |
| Accretion of discount on note payable | 151,200 | 103,893 | 206,760 | 15,353 |
| Amortization of debt issue costs | 5,562 | 4,694 | -133,304 | 155,135 |
| Loss on debt extinguishment | -336,781 | -354,117 | -451,834 | NaN |
| Issuance cost and change in fair value of derivative | NaN | 133,991 | 1,016,682 | NaN |
| Change in fair value of derivative | 852,030 | NaN | NaN | NaN |
| Miscellaneous receivables | NaN | -18,312 | NaN | NaN |
| Other receivables | 53,209 | NaN | -544 | -6,740 |
| Prepaid expenses and other current assets | 919,486 | -248,697 | -7,341 | 879,743 |
| Operating lease right-of-use assets | -56,798 | -54,958 | -53,176 | 1,348,209 |
| Trade accounts payable and accrued expenses | 1,304,682 | 1,311,404 | 1,091,758 | -935,266 |
| Current portion of operating lease liability | 8,000 | 7,741 | 7,490 | 92,971 |
| Long-term portion of operating lease liability | -64,798 | -62,699 | -60,666 | 1,223,587 |
| Net cash used in operating activities | -6,912,960 | -3,597,289 | -4,244,354 | -9,403,539 |
| Purchase of property and equipment | 61,183 | 156,213 | 0 | 5,925 |
| Net cash used in investing activities | -61,183 | -156,213 | 0 | -5,925 |
| Proceeds from the issuance of common stock and common stock purchase warrants, net of fees | 21,913,970 | 2,588,175 | 1,462,881 | 6,102,756 |
| Proceeds from notes payable | NaN | 6,000,000 | NaN | NaN |
| Principal payments on finance lease obligations | NaN | 0 | 0 | 4,430 |
| Net cash provided by financing activities | 21,913,970 | 8,588,175 | 1,462,881 | 6,098,326 |
| Net increase (decrease) in cash and cash equivalents | 14,939,827 | 4,834,673 | -2,781,473 | -3,311,138 |
| Cash and cash equivalents at beginning of year | 10,953,383 | 6,118,710 | 12,211,321 | NaN |
| Cash and cash equivalents at end of period | 25,893,210 | 10,953,383 | 6,118,710 | NaN |
Cingulate Inc. (CINGW)
Cingulate Inc. (CINGW)